Literature DB >> 19124156

Mechanism of interferon-gamma mediated down-regulation of interleukin-10 gene expression.

Annette Schaefer1, Claudia Unterberger, Marion Frankenberger, Marion Lohrum, Karl J Staples, Thomas Werner, Henk Stunnenberg, Loems Ziegler-Heitbrock.   

Abstract

Expression of the anti-inflammatory cytokine IL-10 is suppressed by the pro-inflammatory interferon gamma but the mechanism of this action is unknown. We analysed activity of IL-10 promoter luciferase reporter constructs in transfected RPMI 8226.1 B cells that were treated at -2 h with IFNgamma (1000 U/ml) followed by stimulation with LPS (100 ng/ml) at 0 h. IFNgamma treatment suppressed LPS-induced IL-10 promoter activity in a construct carrying the -1044 promoter and also one containing the -195 promoter. The suppression was independent of the IRF-motif at -182 but involved the Stat-motif at -120. In gelshift analysis this Stat motif did bind LPS-induced Stat3 and with IFNgamma treatment it did, in addition, bind Stat1. ChIP analysis for detection of transcription factor binding to chromatin in intact cells demonstrated Stat3 binding to the proximal IL-10 promoter when cells are stimulated with LPS only. Treatment with IFNgamma only led to Stat1 binding in ChIP analysis and treatment with IFNgamma plus LPS led to reduced Stat3 binding while Stat1 binding remained high. Finally, LPS-induced activity of the trimeric Stat-motif in front of the luciferase reporter was suppressed by IFNgamma. These data demonstrate that IFNgamma down-regulates expression of the IL-10 gene by a novel mechanism that involves displacement of transactiving Stat3 by IFNgamma-induced Stat1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124156     DOI: 10.1016/j.molimm.2008.11.015

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

Review 1.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

2.  Dissecting the Genomic Architecture of Resistance to Eimeria maxima Parasitism in the Chicken.

Authors:  Kay Boulton; Matthew J Nolan; Zhiguang Wu; Valentina Riggio; Oswald Matika; Kimberley Harman; Paul M Hocking; Nat Bumstead; Pat Hesketh; Andrew Archer; Stephen C Bishop; Pete Kaiser; Fiona M Tomley; David A Hume; Adrian L Smith; Damer P Blake; Androniki Psifidi
Journal:  Front Genet       Date:  2018-11-26       Impact factor: 4.599

3.  Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis.

Authors:  Paula Gratal; Juan I Barrasa; Sandra Pérez-Baos; Ana Lamuedra; Olga Sánchez-Pernaute; Gabriel Herrero-Beaumont; Raquel Largo
Journal:  J Inflamm (Lond)       Date:  2019-01-29       Impact factor: 4.981

4.  STAT3 Target Genes Relevant to Human Cancers.

Authors:  Richard L Carpenter; Hui-Wen Lo
Journal:  Cancers (Basel)       Date:  2014-04-16       Impact factor: 6.639

5.  NOD1 modulates IL-10 signalling in human dendritic cells.

Authors:  Theresa Neuper; Kornelia Ellwanger; Harald Schwarz; Thomas A Kufer; Albert Duschl; Jutta Horejs-Hoeck
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

6.  Enhanced gut barrier integrity sensitizes colon cancer to immune therapy.

Authors:  Neal Bhutiani; Qingsheng Li; Charles D Anderson; Heather C Gallagher; Magdia De Jesus; Rajbir Singh; Venkatkrishna R Jala; Mostafa Fraig; Tao Gu; Nejat K Egilmez
Journal:  Oncoimmunology       Date:  2018-08-23       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.